Cytodyn Inc (CYDY)

[Saltz]

5TOP, I think the reason Pro-140 MAB is being held to ARV standards is because it is attempting to disrupt the SOC for HIV. This is a big market that affects millions of lives that is being challenged. As much as BP is not supposed to have influence or leverage over the FDA - they do. With $10 Billion plus in jeopardy Gilead will not go quietly. The results are so powerful they just need to be proven - especially in terms of safety. It seems we are close however the FDA makes me nervous because they have a way of continually lengthening the approval process - the bright spot is they seem to be expediting the process for the Pro-140 cause at the moment. I hope this behavior continues. 2017 will tell the story.